HCA Healthcare - HCA Stock Price Target and Predictions

  • Consensus Rating: Buy
  • Consensus Price Target: $235.10
  • Forecasted Upside: -2.66 %
  • Number of Analysts: 18
  • Breakdown:
  • 1 Sell Ratings
  • 2 Hold Ratings
  • 15 Buy Ratings
  • 0 Strong Buy Ratings
$241.53
▲ +3.42 (1.44%)

This chart shows the closing price for HCA by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New HCA Healthcare Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for HCA and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for HCA

Analyst Price Target is $235.10
▼ -2.66% Downside Potential
This price target is based on 18 analysts offering 12 month price targets for HCA Healthcare in the last 3 months. The average price target is $235.10, with a high forecast of $275.00 and a low forecast of $160.00. The average price target represents a -2.66% upside from the last price of $241.53.

This chart shows the closing price for HCA for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart

Current Consensus is Buy

The current consensus among 18 contributing investment analysts is to buy stock in HCA Healthcare. This Buy consensus rating has held steady for over two years.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 13 buy ratings
  • 2 hold ratings
  • 1 sell ratings
6/15/2021
  • 0 strong buy ratings
  • 15 buy ratings
  • 2 hold ratings
  • 1 sell ratings
9/13/2021
  • 0 strong buy ratings
  • 15 buy ratings
  • 3 hold ratings
  • 1 sell ratings
12/12/2021
  • 0 strong buy ratings
  • 15 buy ratings
  • 3 hold ratings
  • 1 sell ratings
3/12/2022
  • 0 strong buy ratings
  • 16 buy ratings
  • 4 hold ratings
  • 1 sell ratings
6/10/2022
  • 0 strong buy ratings
  • 15 buy ratings
  • 3 hold ratings
  • 1 sell ratings
9/8/2022
  • 0 strong buy ratings
  • 15 buy ratings
  • 2 hold ratings
  • 1 sell ratings
11/7/2022
  • 0 strong buy ratings
  • 15 buy ratings
  • 2 hold ratings
  • 1 sell ratings
12/7/2022

Latest Recommendations

  • 0 strong buy ratings
  • 15 buy ratings
  • 2 hold ratings
  • 1 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
11/2/2022MizuhoBoost TargetBuy$230.00 ➝ $242.00Low
10/27/2022Credit Suisse GroupLower Target$240.00Low
10/26/2022CitigroupBoost TargetBuy$240.00 ➝ $251.00Low
10/25/2022Raymond JamesLower TargetOutperform$250.00 ➝ $230.00Low
10/24/2022StephensLower TargetOverweight$230.00 ➝ $220.00Low
10/24/2022Royal Bank of CanadaLower TargetOutperform$249.00 ➝ $239.00Low
10/24/2022SVB LeerinkLower TargetOutperform$252.00 ➝ $238.00Low
10/24/2022OppenheimerLower TargetOutperform$255.00 ➝ $235.00Low
10/24/2022Wells Fargo & CompanyBoost TargetEqual Weight$199.00 ➝ $217.00Low
9/16/2022Raymond JamesBoost TargetOutperform$230.00 ➝ $250.00Low
8/24/2022SVB LeerinkBoost TargetOutperform$240.00 ➝ $259.00Low
8/2/2022MizuhoBoost TargetBuy$210.00 ➝ $230.00Low
7/26/2022UBS GroupBoost Target$227.00Low
7/26/2022CitigroupLower Target$254.00 ➝ $240.00Low
7/25/2022StephensBoost Target$230.00Low
7/25/2022CowenLower Target$238.00Low
7/25/2022Credit Suisse GroupBoost TargetOutperform$230.00 ➝ $250.00Low
7/25/2022SVB LeerinkBoost TargetOutperform$212.00 ➝ $240.00Low
7/25/2022Truist FinancialBoost TargetBuy$208.00 ➝ $240.00Low
7/24/2022Bank of AmericaBoost Target$192.00 ➝ $230.00Low
7/19/2022Credit Suisse GroupSet Target$230.00Low
7/15/2022SVB LeerinkLower TargetOutperform$273.00 ➝ $212.00Low
7/12/2022The Goldman Sachs GroupLower TargetBuy$270.00 ➝ $233.00N/A
7/11/2022Raymond JamesLower TargetOutperform$245.00 ➝ $220.00N/A
7/7/2022Deutsche Bank AktiengesellschaftLower TargetBuy$306.00 ➝ $200.00N/A
7/6/2022BMO Capital MarketsDowngradeMarket Perform ➝ Underperform$233.00 ➝ $160.00N/A
7/1/2022MizuhoLower TargetBuy$260.00 ➝ $210.00Low
6/21/2022Royal Bank of CanadaLower TargetOutperform$267.00 ➝ $256.00Low
6/20/2022OppenheimerSet Target$255.00Low
6/16/2022Loop CapitalInitiated CoverageBuy$240.00Medium
5/26/2022Sanford C. BernsteinUpgradeMarket Perform ➝ Outperform$273.00 ➝ $271.00Low
5/3/2022MizuhoLower Target$290.00 ➝ $260.00Medium
4/26/2022BMO Capital MarketsLower Target$275.00 ➝ $240.00High
4/26/2022Raymond JamesLower TargetOutperform$275.00 ➝ $245.00High
4/26/2022UBS GroupLower TargetBuy$289.00 ➝ $241.00High
4/25/2022CowenLower Target$265.00 ➝ $241.00Low
4/25/2022Truist FinancialLower TargetBuy$310.00 ➝ $250.00Medium
4/25/2022Jefferies Financial GroupLower Target$310.00 ➝ $275.00Low
4/25/2022Wells Fargo & CompanyLower TargetEqual Weight$267.00 ➝ $227.00Low
4/25/2022CowenLower Target$265.00 ➝ $241.00Low
4/25/2022SVB LeerinkLower TargetOutperform$304.00 ➝ $273.00Medium
4/25/2022Royal Bank of CanadaLower TargetOutperform$291.00 ➝ $267.00Low
4/25/2022CitigroupLower TargetBuy$277.00 ➝ $254.00Low
4/25/2022Credit Suisse GroupLower TargetOutperform$296.00 ➝ $260.00Medium
3/28/2022Wells Fargo & CompanyInitiated CoverageEqual Weight$267.00Low
1/28/2022CowenLower TargetOutperform$302.00 ➝ $265.00High
1/28/2022SVB LeerinkLower TargetOutperform$320.00 ➝ $304.00High
1/5/2022Truist FinancialBoost TargetBuy ➝ Buy$290.00 ➝ $310.00High
12/21/2021JPMorgan Chase & Co.DowngradeOverweight ➝ Neutral$270.00Medium
12/20/2021MizuhoBoost TargetBuy$275.00 ➝ $290.00High
10/26/2021Raymond JamesBoost TargetOutperform$290.00 ➝ $300.00Low
10/25/2021William BlairReiterated RatingMarket PerformLow
10/25/2021StephensBoost TargetOverweight$275.00 ➝ $283.00High
10/25/2021Deutsche Bank AktiengesellschaftBoost TargetBuy$275.00 ➝ $306.00High
10/25/2021CitigroupBoost TargetNeutral$268.00 ➝ $274.00High
10/25/2021Royal Bank of CanadaBoost TargetOutperform$273.00 ➝ $291.00High
10/25/2021Credit Suisse GroupBoost TargetOutperform$267.00 ➝ $298.00High
10/25/2021OppenheimerBoost TargetOutperform$275.00 ➝ $290.00High
9/27/2021SVB LeerinkInitiated CoverageOutperform$320.00Low
9/23/2021UBS GroupInitiated CoverageBuy$312.00Low
9/9/2021CowenInitiated CoverageOutperform$293.00Low
8/27/2021BarclaysReiterated RatingHold ➝ NeutralLow
8/12/2021BarclaysDowngradeOverweight ➝ Equal Weight$275.00 ➝ $267.00Low
8/6/2021The Goldman Sachs GroupBoost TargetBuy$252.00 ➝ $279.00Low
7/22/2021BarclaysBoost TargetOverweight$225.00 ➝ $275.00Low
7/21/2021Truist FinancialBoost TargetBuy$260.00 ➝ $290.00Medium
7/21/2021Credit Suisse GroupBoost TargetOutperform$222.00 ➝ $267.00Low
7/21/2021MizuhoBoost TargetBuy$232.00 ➝ $275.00Low
7/21/2021Raymond JamesBoost TargetOutperform$225.00 ➝ $290.00Low
7/21/2021Royal Bank of CanadaBoost TargetOutperform$247.00 ➝ $273.00Low
7/21/2021OppenheimerBoost TargetOutperform$230.00 ➝ $275.00Low
7/21/2021Deutsche Bank AktiengesellschaftBoost TargetBuy$225.00 ➝ $275.00Low
7/21/2021BMO Capital MarketsBoost TargetMarket Perform$235.00 ➝ $250.00Low
7/21/2021CitigroupBoost TargetNeutral$215.00 ➝ $268.00Low
7/19/2021The Goldman Sachs GroupBoost TargetBuy$223.00 ➝ $252.00Low
7/9/2021Seaport Res PtnReiterated RatingBuyLow
6/18/2021Jefferies Financial GroupReiterated RatingBuyHigh
4/29/2021Raymond JamesReiterated RatingOutperform$190.00 ➝ $225.00Medium
4/29/2021Royal Bank of CanadaBoost TargetOutperform$205.00 ➝ $232.00N/A
4/29/2021MizuhoBoost TargetBuy$205.00 ➝ $232.00N/A
4/26/2021CitigroupDowngradeBuy ➝ NeutralLow
4/26/2021Deutsche Bank AktiengesellschaftBoost TargetBuy$210.00 ➝ $225.00Low
4/26/2021BMO Capital MarketsBoost TargetMarket Perform$200.00 ➝ $222.00Low
4/23/2021Raymond JamesBoost TargetOutperform$190.00 ➝ $225.00Low
4/23/2021OppenheimerBoost TargetOutperform$200.00 ➝ $230.00Low
4/23/2021BarclaysBoost TargetOverweight$195.00 ➝ $225.00High
4/23/2021MizuhoBoost TargetBuy$205.00 ➝ $232.00High
4/23/2021Royal Bank of CanadaBoost TargetOutperform$205.00 ➝ $232.00High
4/19/2021Deutsche Bank AktiengesellschaftBoost TargetBuy$210.00 ➝ $225.00N/A
4/14/2021Truist FinancialBoost TargetBuy$200.00 ➝ $230.00Low
4/13/2021Deutsche Bank AktiengesellschaftBoost TargetBuy$180.00 ➝ $210.00Medium
4/9/2021MizuhoBoost TargetBuy$195.00 ➝ $205.00Medium
2/5/2021MizuhoBoost TargetBuy$180.00 ➝ $195.00Medium
2/4/2021UBS GroupBoost TargetBuy$164.00 ➝ $203.00High
2/3/2021CitigroupBoost Target$185.00 ➝ $191.00Low
2/3/2021Credit Suisse GroupBoost TargetOutperform$197.00 ➝ $201.00High
2/3/2021Raymond JamesBoost TargetOutperform$150.00 ➝ $190.00High
1/5/2021Truist FinancialBoost Target$165.00 ➝ $190.00N/A
1/5/2021Deutsche Bank AktiengesellschaftBoost TargetBuy$150.00 ➝ $180.00N/A
12/18/2020MizuhoBoost TargetBuy$170.00 ➝ $180.00Low
12/15/2020The Goldman Sachs GroupInitiated CoverageBuy$191.00Medium
12/14/2020JPMorgan Chase & Co.UpgradeNeutral ➝ Overweight$143.00 ➝ $194.00High
12/7/2020MizuhoBoost TargetBuy$150.00 ➝ $170.00Medium
11/11/2020Piper SandlerBoost TargetOverweight$149.00 ➝ $163.00High
10/27/2020Smith Barney CitigroupBoost Target$142.00 ➝ $155.00Medium
10/27/2020Piper SandlerBoost TargetNeutral$138.00 ➝ $149.00High
10/27/2020Raymond JamesBoost TargetOutperform$140.00 ➝ $150.00High
10/27/2020Credit Suisse GroupBoost TargetOutperform$158.00 ➝ $164.00High
10/27/2020MizuhoBoost TargetBuy$145.00 ➝ $150.00High
10/27/2020BarclaysBoost TargetOverweight$140.00 ➝ $150.00High
10/9/2020CSFBBoost TargetOutperform$143.00 ➝ $158.00Medium
10/9/2020Credit Suisse GroupBoost TargetOutperform$143.00 ➝ $158.00High
9/21/2020JPMorgan Chase & Co.DowngradeOverweight ➝ Neutral$161.00 ➝ $143.00High
9/16/2020Truist FinancialBoost TargetBuy$150.00 ➝ $165.00Low
7/24/2020JPMorgan Chase & Co.Boost TargetOverweight$142.00 ➝ $161.00Low
7/23/2020OppenheimerBoost Target$135.00 ➝ $140.00High
7/23/2020Deutsche Bank AktiengesellschaftBoost Target$132.00 ➝ $150.00Medium
7/23/2020Piper SandlerBoost TargetNeutral$132.00 ➝ $138.00Low
7/23/2020Raymond JamesBoost TargetCautious ➝ Outperform$130.00 ➝ $140.00High
7/23/2020SunTrust BanksBoost TargetBuy$130.00 ➝ $150.00High
7/23/2020MizuhoBoost TargetBuy$136.00 ➝ $145.00High
7/23/2020CitigroupBoost TargetBuy$131.00 ➝ $142.00High
7/13/2020BMO Capital MarketsDowngradeOutperform ➝ Market Perform$121.00 ➝ $100.00Low
6/11/2020UBS GroupLower TargetBuy$138.00 ➝ $137.00High
5/29/2020MizuhoLower TargetBuy$150.00 ➝ $136.00High
5/20/2020CitigroupLower TargetBuy$168.00 ➝ $131.00Medium
4/27/2020UBS GroupLower TargetBuy$183.00 ➝ $138.00Low
4/22/2020SunTrust BanksLower TargetBuy$160.00 ➝ $140.00Medium
4/22/2020BarclaysBoost TargetOverweight$117.00 ➝ $127.00Medium
4/22/2020Deutsche Bank AktiengesellschaftLower TargetBuy$165.00 ➝ $132.00Medium
4/22/2020OppenheimerLower TargetOutperform$160.00 ➝ $135.00Medium
4/20/2020Raymond JamesLower TargetOutperform$165.00 ➝ $130.00High
4/13/2020SunTrust BanksLower TargetBuy$185.00 ➝ $160.00High
3/25/2020BarclaysReiterated RatingBuy$117.00High
3/19/2020Credit Suisse GroupReiterated RatingBuy$173.00Low
2/3/2020BarclaysBoost TargetOverweight ➝ Positive$172.00 ➝ $177.00Low
1/29/2020SunTrust BanksReiterated RatingBuy$185.00Medium
1/29/2020Robert W. BairdBoost TargetOutperform$160.00 ➝ $180.00Low
1/29/2020Credit Suisse GroupBoost TargetOutperform$169.00 ➝ $173.00Low
1/29/2020StephensBoost TargetOverweight$175.00 ➝ $180.00Medium
1/29/2020CitigroupBoost TargetBuy$156.00 ➝ $168.00Medium
1/29/2020Royal Bank of CanadaBoost TargetOutperform$170.00 ➝ $173.00Medium
1/27/2020The Goldman Sachs GroupReiterated RatingBuy$165.00High
1/3/2020Deutsche Bank AktiengesellschaftInitiated CoverageBuy$140.00Low
12/20/2019JPMorgan Chase & Co.Boost TargetOverweight$157.00 ➝ $186.00Low
12/6/2019Bank of AmericaUpgradeNeutral ➝ BuyHigh
10/30/2019BarclaysBoost TargetOverweight$145.00 ➝ $155.00Low
9/6/2019Bank of AmericaUpgradeUnderperform ➝ Neutral$130.00 ➝ $137.00Medium
8/7/2019StephensSet TargetBuy$150.00Low
7/31/2019MizuhoSet TargetBuy$153.00N/A
7/10/2019The Goldman Sachs GroupUpgradeNeutral ➝ Buy$147.00 ➝ $160.00Low
6/24/2019UBS GroupBoost TargetBuy$172.00 ➝ $181.00Medium
5/1/2019UBS GroupBoost TargetBuy ➝ Buy$164.00 ➝ $172.00Low
5/1/2019Deutsche Bank AktiengesellschaftBoost TargetBuy ➝ Buy$160.00 ➝ $165.00Medium
4/23/2019Raymond JamesUpgradeMarket Perform ➝ Outperform$115.00 ➝ $135.00High
4/17/2019Jefferies Financial GroupSet TargetBuy$158.00High
4/17/2019BarclaysLower TargetOverweight ➝ Overweight$155.00 ➝ $145.00Low
1/30/2019OppenheimerBoost TargetOutperform$142.00 ➝ $150.00Low
1/30/2019SunTrust BanksBoost TargetBuy$175.00Low
1/30/2019SVB LeerinkBoost TargetOutperform$160.00 ➝ $175.00Low
1/14/2019StephensInitiated CoverageOverweight$143.00Low
1/3/2019Deutsche Bank AktiengesellschaftInitiated CoverageBuy ➝ Buy$140.00Medium
11/15/2018UBS GroupInitiated CoverageBuy ➝ Buy$162.00Medium
11/6/2018ArgusBoost TargetBuy ➝ Buy$150.00 ➝ $155.00Low
11/1/2018Credit Suisse GroupBoost TargetOutperform ➝ Outperform$156.00 ➝ $165.00Low
10/31/2018Jefferies Financial GroupBoost TargetBuy ➝ Buy$155.00 ➝ $158.00Low
10/11/2018CitigroupBoost TargetBuy$136.00 ➝ $156.00Medium
9/21/2018Jefferies Financial GroupBoost TargetBuy$155.00Low
9/20/2018Robert W. BairdBoost TargetOutperform ➝ Positive$130.00 ➝ $150.00Low
9/18/2018Bank of AmericaBoost TargetUnderperform$125.00 ➝ $135.00Medium
9/10/2018Royal Bank of CanadaBoost TargetOutperform$150.00Low
9/7/2018ArgusBoost TargetBuy$150.00Low
9/5/2018Morgan StanleyBoost TargetUnderweight ➝ Underweight$115.00 ➝ $124.00Low
9/5/2018BMO Capital MarketsBoost TargetOutperform ➝ Buy$145.00 ➝ $155.00Low
9/4/2018SunTrust BanksBoost TargetBuy ➝ Positive$150.00High
9/4/2018SVB LeerinkBoost TargetOutperform ➝ Outperform$140.00 ➝ $150.00Low
9/4/2018MizuhoSet TargetBuy$150.00Low
8/16/2018Morgan StanleyBoost TargetUnderweight ➝ Underweight$105.00 ➝ $115.00Medium
8/14/2018BarclaysInitiated CoverageOverweight$150.00Low
8/2/2018MizuhoReiterated RatingBuy$145.00Low
7/30/2018JPMorgan Chase & Co.Boost TargetOverweight$151.00Low
7/27/2018Credit Suisse GroupBoost TargetOutperform ➝ Outperform$122.00 ➝ $143.00Low
7/26/2018Piper Jaffray CompaniesReiterated RatingHold$124.00Low
7/26/2018Jefferies Financial GroupReiterated RatingBuy$135.00Medium
7/26/2018SunTrust BanksBoost TargetBuy$145.00High
7/26/2018SVB LeerinkBoost TargetOutperform$125.00 ➝ $140.00High
7/20/2018Cantor FitzgeraldReiterated RatingBuy$115.00Low
7/20/2018SunTrust BanksReiterated RatingBuy$125.00Low
7/13/2018Morgan StanleyBoost TargetUnderweight$91.00 ➝ $98.00Low
3/23/2018MizuhoInitiated CoverageBuy$115.00Medium
2/12/2018ArgusBoost TargetPositive ➝ Buy$9.26 ➝ $114.00Low
2/1/2018Sanford C. BernsteinReiterated RatingMarket Perform$105.00 ➝ $116.00Low
2/1/2018BMO Capital MarketsBoost TargetOutperform ➝ Outperform$96.00 ➝ $115.00Low
2/1/2018Morgan StanleyBoost TargetUnderweight ➝ Underweight$84.00 ➝ $91.00Low
1/31/2018Royal Bank of CanadaBoost TargetOutperform$117.00Low
1/31/2018Credit Suisse GroupBoost TargetOutperform ➝ Outperform$115.00 ➝ $122.00Low
1/31/2018SVB LeerinkBoost TargetOutperform ➝ Outperform$105.00 ➝ $120.00Low
1/31/2018SunTrust BanksBoost TargetBuy ➝ Positive$120.00Low
1/30/2018Piper Jaffray CompaniesReiterated RatingHold$101.00Low
1/30/2018Cantor FitzgeraldReiterated RatingBuy$115.00High
1/30/2018Wells Fargo & CompanyInitiated CoverageOutperform ➝ Outperform$116.00High
1/24/2018William BlairReiterated RatingHoldMedium
1/12/2018Robert W. BairdSet TargetBuy$104.00Medium
1/10/2018ArgusSet TargetBuy$97.00Low
1/4/2018Bank of AmericaDowngradeNeutral ➝ Underperform$94.00 ➝ $90.00Medium
1/3/2018The Goldman Sachs GroupInitiated CoverageNeutral ➝ NeutralHigh
1/3/2018Piper Jaffray CompaniesDowngradeOverweight ➝ Neutral$81.00High
12/26/2017Credit Suisse GroupReiterated RatingOutperform$25.00Low
12/21/2017SunTrust BanksSet TargetBuy$105.00Low
12/20/2017Morgan StanleyDowngradeEqual Weight ➝ Underweight$85.00High
12/12/2017CitigroupUpgradeNeutral ➝ BuyMedium
(Data available from 12/8/2017 forward)

News Sentiment Rating

0.48 (Hold)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 13 very positive mentions
  • 46 positive mentions
  • 12 negative mentions
  • 1 very negative mentions
5/12/2022
  • 6 very positive mentions
  • 17 positive mentions
  • 2 negative mentions
  • 2 very negative mentions
6/11/2022
  • 3 very positive mentions
  • 19 positive mentions
  • 4 negative mentions
  • 2 very negative mentions
7/11/2022
  • 7 very positive mentions
  • 52 positive mentions
  • 9 negative mentions
  • 0 very negative mentions
8/10/2022
  • 4 very positive mentions
  • 19 positive mentions
  • 5 negative mentions
  • 4 very negative mentions
9/9/2022
  • 13 very positive mentions
  • 19 positive mentions
  • 7 negative mentions
  • 1 very negative mentions
10/9/2022
  • 10 very positive mentions
  • 57 positive mentions
  • 7 negative mentions
  • 4 very negative mentions
11/8/2022
  • 13 very positive mentions
  • 20 positive mentions
  • 4 negative mentions
  • 1 very negative mentions
12/8/2022

Current Sentiment

  • 13 very positive mentions
  • 20 positive mentions
  • 4 negative mentions
  • 1 very negative mentions

Recent Stories by Sentiment

HCA Healthcare logo
HCA Healthcare, Inc., through its subsidiaries, provides health care services company in the United States. The company operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy. It also operates outpatient health care facilities consisting of freestanding ambulatory surgery centers, freestanding emergency care facilities, urgent care facilities, walk-in clinics, diagnostic and imaging centers, rehabilitation and physical therapy centers, radiation and oncology therapy centers, physician practices, and various other facilities. In addition, the company operates psychiatric hospitals, which provide therapeutic programs comprising child, adolescent and adult psychiatric care, adolescent and adult alcohol, drug abuse treatment, and counseling services. As of December 31, 2021, it operated 182 hospitals, including 175 general and acute care hospitals, five psychiatric hospitals, and two rehabilitation hospitals; 125 freestanding surgery centers; and 21 freestanding endoscopy centers in 20 states and England. The company was formerly known as HCA Holdings, Inc. HCA Healthcare, Inc. was founded in 1968 and is headquartered in Nashville, Tennessee.
Read More

Today's Range

Now: $241.53
Low: $238.01
High: $242.27

50 Day Range

MA: $217.43
Low: $183.79
High: $240.22

52 Week Range

Now: $241.53
Low: $164.47
High: $279.02

Volume

1,187,951 shs

Average Volume

1,687,376 shs

Market Capitalization

$68.28 billion

P/E Ratio

13.65

Dividend Yield

0.94%

Beta

1.69

Frequently Asked Questions

What sell-side analysts currently cover shares of HCA Healthcare?

The following sell-side analysts have issued research reports on HCA Healthcare in the last year: Bank of America Co., BMO Capital Markets, Citigroup Inc., Cowen Inc, Cowen Inc., Credit Suisse Group AG, Deutsche Bank Aktiengesellschaft, Jefferies Financial Group Inc., JPMorgan Chase & Co., Loop Capital, Mizuho, Oppenheimer Holdings Inc., Raymond James, Royal Bank of Canada, Sanford C. Bernstein, Stephens, StockNews.com, SVB Leerink LLC, The Goldman Sachs Group, Inc., TheStreet, Truist Financial Co., UBS Group AG, and Wells Fargo & Company.
View the latest analyst ratings for HCA.

What is the current price target for HCA Healthcare?

21 Wall Street analysts have set twelve-month price targets for HCA Healthcare in the last year. Their average twelve-month price target is $235.10, suggesting a possible downside of 2.7%. Jefferies Financial Group Inc. has the highest price target set, predicting HCA will reach $275.00 in the next twelve months. BMO Capital Markets has the lowest price target set, forecasting a price of $160.00 for HCA Healthcare in the next year.
View the latest price targets for HCA.

What is the current consensus analyst rating for HCA Healthcare?

HCA Healthcare currently has 1 sell rating, 2 hold ratings and 15 buy ratings from Wall Street analysts. The stock has a consensus analyst rating of "Buy." A "buy" rating indicates that analysts believe HCA will outperform the market and that investors should add to their positions of HCA Healthcare.
View the latest ratings for HCA.

What other companies compete with HCA Healthcare?

Other companies that are similar to HCA Healthcare include Moderna, Boston Scientific, Humana, Becton, Dickinson and and Zoetis. Learn More about companies similar to HCA Healthcare.

How do I contact HCA Healthcare's investor relations team?

HCA Healthcare's physical mailing address is ONE PARK PLAZA, NASHVILLE TN, 37203. The company's listed phone number is (615) 344-9551 and its investor relations email address is [email protected] The official website for HCA Healthcare is www.hcahealthcare.com. Learn More about contacing HCA Healthcare investor relations.